← FDA DRUG APPROVALS

FDA ANDA · ANDA084999

WYGESIC

Sponsor: CARACO

APPLICATION
ANDA084999
TYPE
ANDA
ORIGINAL APPROVAL
1976-09-03
LATEST ACTION
1990-02-20
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

WYGESICDiscontinued
ACETAMINOPHEN 650MG, PROPOXYPHENE HYDROCHLORIDE 65MG · TABLET · ORAL

Approval history

1990-02-20Labeling · Supplement 22AP
1989-09-01Manufacturing (CMC) · Supplement 25AP
1989-09-01Manufacturing (CMC) · Supplement 23AP
1989-09-01Manufacturing (CMC) · Supplement 26AP
1989-09-01Manufacturing (CMC) · Supplement 24AP
1989-09-01Manufacturing (CMC) · Supplement 27AP
1983-12-06Manufacturing (CMC) · Supplement 17AP
1983-12-06Manufacturing (CMC) · Supplement 16AP
1976-09-03OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →